Evercore ISI Group Maintains Outperform on Boston Scientific, Raises Price Target to $72
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group analyst Vijay Kumar has maintained an Outperform rating on Boston Scientific (NYSE:BSX) and increased the price target from $68 to $72.
April 04, 2024 | 4:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evercore ISI Group has maintained an Outperform rating on Boston Scientific and raised the price target from $68 to $72.
The maintenance of an Outperform rating combined with an increase in the price target by a reputable analyst firm like Evercore ISI Group suggests a positive outlook on Boston Scientific's stock. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100